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The problem of cancer risk analysis is of great importance to health-service providers
and medical researchers. In this study, we propose a novel Artificial Neural Network
(ANN) algorithm based on the probabilistic framework, which aims to investigate patient
patterns associated with their disease development. Compared to the traditional ANN
where input features are directly extracted from raw data, the proposed probabilistic
ANN manipulates original inputs according to their probability distribution. More precisely,
the Naïve Bayes and Markov chain models are used to approximate the posterior
distribution of the raw inputs, which provides a useful estimation of subsequent disease
development. Later, this distribution information is further leveraged as additional input
to train ANN. Additionally, to reduce the training cost and to boost the generalization
capability, a sparse training strategy is also introduced. Experimentally, one of the largest
cancer-related datasets is employed in this study. Compared to state-of-the-art methods,
the proposed algorithm achieves a much better outcome, in terms of the prediction
accuracy of subsequent disease development. The result also reveals the potential
impact of patients’ disease sequence on their future risk management.
Keywords: cancer risk analysis, artificial neural network, Naïve Bayes, Markov chain, sparse training

1. INTRODUCTION
Cancer is a complex health problem worldwide, which is closely monitored by scientists and
authorities due to its high mortality rate. In the past decades, the pressure of cancer in public health
sectors has gradually increased. A lot of effort has been put into cancer-related studies (Loud and
Murphy, 2017), such as patient status monitoring, medical resource allocation, and survivability
prediction, to name a few. According to the GLOBOCAN project (Sasikala et al., 2019), there will be
more than 14.1 million new cancer-related cases (excluding skin cancer and melanoma) annually,
accounting for ∼14.6% of global deaths. Even within developed countries, such as the United States,
there are more than 1.68 million new patients and 600,000 deaths per year. In particular, Table 1
shows the top eight cancer types from the United States in 2016, while the number of new cases
and relevant deaths are also illustrated. For instance, there are about 150,000 new cases diagnosed
with breast cancer and around 41,000 deaths, which contribute to a 16.4% ratio between new cases
and death numbers. On the other hand, there are ∼24,000 new patients and 16,000 deaths related
to brain and nervous system cancers, which leads to a significantly high ratio of 67.5%.
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widely-used techniques for simulation and modeling, due to its
ability to learn from complex inputs and to produce accurate
outputs. Not surprisingly, we have observed a great number of
ANN-based applications in the medical domain. For example,
the work from Fakoor et al. (2013) developed a hybrid method
by combining ANN with the Support Vector Machine and it was
tested on several gene-expression datasets for cancer detection.
The results revealed that the ANN-based work outperformed
traditional methods via discovering intricate relationships behind
risk factors. More recently, a convolutional neural network
improvement for breast cancer classification was proposed in
Ting et al. (2019). To classify incoming medical images into
malignant, benign, and healthy patients, their work performed
effectively to localize and identify breast cancer tissue. Other
successful implementations of ANN-based models can be found
in the survey of Siddiqui et al. (2020).
Despite the general interest in developing the ANN
applications, several drawbacks still exist. Specifically, in
the context of the disease development, we aim to explore the
disease correlation and to identify related risk factors. The
majority of traditional ANN applications, however, consider
network inputs from the original data directly, while less work
has been offered in terms of the input amendment or augment.
On the other hand, the standard network training process is
usually time consuming, in particular with a large number
of inputs. Additionally, as for some real-world scenarios, the
generalization performance of the standard ANN is far from
being satisfactory.
To this end, in this study we propose a novel hybrid algorithm,
based on the idea of Artificial Neural Network, Naïve Bayes,
and Markov chain, to address the issue of predicting patients’
disease development. In the proposed study, the methods of
Naïve Bayes and Markov chain are first applied to estimate
posterior possibilities of subsequent development, according
to the patient’s historical data. The estimation of subsequent
possibility is able to establish a relationship model via capturing
the underlying correlation of the disease development. Next,
estimated possibilities are further leveraged as the input to the
neural network, in addition to original inputs. Lastly, we also
consider adopting a sparse training strategy for the network
training, which is able to optimize the network structure and
minimize the training error simultaneously. To the best of our
knowledge, this is the first investigation combining the models
of Bayesian Network and Markov chain to amend the input
of the Artificial Neural Network. The proposed algorithm is
further applied to one of the largest cancer-related datasets
worldwide, and the comparison with state-of-the-art approaches
is also considered.
The rest of this paper is organized as follows. Section 2
provides a review of literature in which several existing research
topics are examined, including applications of data-mining
techniques on the domain of cancer risk analysis, Artificial
Neural Network, Naïve Bayes and Markov chain model. Section
3 provides the basic information about the research background,
such as the description of the target dataset used in this study.
Section 4 describes the proposed hybrid approach, including the
input augment and sparse training. Then, section 5 discusses

TABLE 1 | Number of new cancer-related patients and deaths from the
United States in 2016.
Cancer types

New cases

New deaths

Digestive system

304,930

153,030

Respiratory system

243,820

162,510

Breast

149,260

40,890

Reproductive system

297,530

57,730

Urinary system

143,190

31,540

Lymphoma

81,080

21,270

Leukemia

60,140

24,400

Brain and other nervous systems

23,770

16,050

As such, the problem of how to monitor and predict
cancer-disease development (to reduce its incidence rate) has
attracted a lot of attention from different public and private
sectors, and has become a major challenge and research focus.
The last two decades have witnessed a huge development of
computer science and information technologies, which have
already taken on an important role in the cancer-related
domain. In particular, data mining and machine learning
approaches are more regularly employed due to their high
performance in simulation and modeling. For example, the work
in Heidari et al. (2018) proposed a machine learning based
model to identify mammographic image features for shortterm breast cancer prediction. Locally preserving projection
(LPP) based features were considered, and the experiment
was performed using a mammographic dataset collected from
500 women. The result further showed a huge improvement
from their work compared to standard methods, such as the
Liner Regression and Decision Tree methods. Additionally, a
comparison between the Naïve Bayes and K-Nearest Neighbor
(KNN) algorithms was provided in Amrane et al. (2018) for
breast cancer classification. The experiment was performed
using the Wisconsin dataset, while the result showed that
KNN outperforms Naïve Bayes with the higher accuracy of
97.51% compared to that of 96.19%. Another breast cancer
prediction work has been reported in Jamal et al. (2018),
in which authors utilized the hybrid technique of Extreme
Gradient Boosting technique and Support Vector Machine.
Furthermore, they also applied the Principle Component
Analysis (PCA) and K-Means Clustering method to reduce
the problem dimensionality. Experimental results illustrated
that the hybrid algorithm with a reduced-scale problem
indeed improved the prediction performance of diagnosing
breast cancer.
However, the majority of the existing research did not address
the sequential nature of the disease’s development. In other
words, less work has been performed to explore the relationship
between patients’ previous disease and sequential ones. As a
result, in this study our research aims to provide new insight
into how disease development can be influenced or predicted
based on patients’ previous medical information. In particular,
the Artificial Neural Network (ANN) algorithm is investigated
as the optimization tool in our study. ANN is one of the most
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prediction, and statistical simulation, and so on. The most
basic computing unit from ANN is the artificial neuron. Those
neurons are designed in a similar way to biological neurons
within the human brain. In general, input signals are transferred
to biological neurons, and then inputs are further processed
within their cell bodies. If a certain threshold is reached,
neurons are activated to transfer output signals to other neurons.
Accordingly, the artificial neuron follows the same procedure
of biological neurons: input receiving, threshold activation, and
output transferring. Mathematically, suppose the input signal to
the i-th neuron is a vector of xi , the connection strength to the
output is the weight wi , and its bias input is represented as b.
Given the activation function f (·), the output for this i-th neuron
can be expressed as follows:

experiments and comparison results, and finally section 6
concludes the study.

2. LITERATURE REVIEW
In this section, we will provide a brief review about existing
cancer-related research. Then the fundamental work of Artificial
Neural Network, Naïve Bayes and Markov chain model is
also provided.

2.1. Cancer Risk Analysis
Cancer risk analysis is of great significance to healthcare
providers and medical researchers. Several research works have
attempted to provide a diverse range of the management and/or
prediction strategies for cancer risk analysis. The ultimate goal is
to provide precaution for people with a risk, as well as to monitor
the disease development (or survivability prediction).
For the risk prediction, the work from Hart et al. (2018)
employed a multi-parameterized neural network for lung cancer
risk prediction, based on putative risk factors as well as clinical
and demographic information. A comparison among Decision
Tree, Support Vector Machine, Naïve Bayes, and K-Nearest
Neighbors was conducted for a liver-cancer assessment. On the
other hand, cancer survivability prediction is also an interesting
topic that has been fervently researched throughout the years.
The prediction task of cancer survivability is to monitor the
possible survivability (the time span) based on the patient’s status.
For instance, Mayur et al. conducted a study on spinal cord
cancer survivability by performing statistical analyses and fitting
a Random Forest model (Mayur et al., 2019). The work from
Wang et al. (2019) investigated the use of a tree ensemblebased two-stage regression model for advanced-stage lung cancer
survival prediction. In addition, a comparison among multiple
techniques, including Linear Regression, Decision Tree, Random
Forest and Generalized Boosting Machines, and Support Vector
Machine, was considered in Sharaf et al. (2015) to predict lungcancer patient survival.
Despite the great interest in the work of cancer risk
and survivability analysis, little research has been done in
terms of the relationship between patients’ past and current
diagnoses. In other words, existing studies fail to address the
possibility of subsequent diagnosis, given patients’ previous
medical conditions. Yet, this research question is of great
importance, as it helps in providing prior knowledge of patients’
future disease development. To gain an in-depth understanding
of potential risk for subsequent diseases also works in increasing
the healthcare quality and treatment services (Gupta et al., 2012;
Aolin and Maxim, 2017). To bridge this gap, we propose a
probabilistic model that takes into account the techniques of the
Artificial Neural Network, Naïve Bayes, and Markov chain model.

y = f (xTi wi + b).

In real-world applications, the selection of activation function
and network structure (the number of hidden layers and/or
neurons) is problematic. In general, there is no commonlyaccepted formula giving clear insight into how to choose the
activation function and/or to determine the network structure.
This is usually decided by trial-and-error experiments or cross
validation methods. Additionally, after deciding the activation
function and network structure, a training process is required
to update the internal network weights to minimize the error
between the actual network and desired output. Some typical
learning algorithms are Back Propagation, Resilient Propagation,
and so on.

2.3. Naïve Bayes and Markov Chain
Bayesian theory offers a computational framework for estimating
the conditional probability, which has proven to be effective for
a wide range of applications. Text classification, spam detection,
and sentiment analysis are just a few of their popular use cases.
Assume that we have one training sample x and n possible class
labels ci (∀i ∈ n). Then the posterior probability (for x) of
belonging to the i-th class [or prob(ci |x)] can be expressed as:
prob(ci |x) =

prob(x|ci )prob(ci )
, ∀i ∈ n,
prob(x)

(2)

where prob(ci ) stands for the class prior probability, prob(x) is
the prior probability of x, and prob(x|ci ) denotes the posterior
probability of x given the condition of the ci class.
Compared with other classification modes, Naïve Bayes
(NB) consumes much less training time, and it can effectively
solve small-scale learning problems. For instance, Kim et al.
(2018) introduced a Naïve Bayes based text classification in
a semantic tensor space model for document representation.
URL classification is another classification application of Native
Bayes, which is currently of research interest (Rajalakshmi and
Aravindan, 2018). In addition, evaluation of a hot-engine test
(Fan et al., 2018) and classification of impact damage on a rubbertextile conveyor belt (Andrejiova and Grincova, 2018) are just
other use cases that have been investigated using the Naïve Bayes
method, respectively.

2.2. Artificial Neural Network
The Artificial Neural Network (ANN) is one of the most
popular data-mining algorithms, which is capable of responding
to complex inputs and generating desired outputs. Due to its
satisfactory performance and high accuracy, ANN has found its
wide applications in numerous areas, such as pattern recognition,
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On the other hand, the Markov chain model is usually utilized
to calculate the transition probability from one state to another.
In particular, the first order Markov chain operates under the
assumption that future states for one particular object (or event)
only depend on the current state, but not on other states that
occurred before. In other words, let xi (i = 1, 2, · · · , n) represent
a sequence of random variables. Then the probability of moving
to the next state (or xn+1 ) is estimated as:
prob(xn+1 |(xn , xn−1 , · · · , x1 )) = prob(xn+1 |xn ).

(3)

The Markov chain model proves to be effective in factoring
the sequential characteristics of events. Existing applications
of the Markov chain model are primarily in the domain of
recommendation, speech recognition, and so on. For instance,
Ye et al. (2015) and Lassoued et al. (2017) both discussed the use
of Markov models in driving route and destination predictions,
respectively. Krause and Zhang (2019) proposed a different
approach by employing a hierarchical Markov model for shortterm behavior prediction. Kurashima et al. (2013) had a slightly
different approach when employing not only the Markov Chain
model but also a topic model to represent the user interest.

FIGURE 1 | Percentage of selected patients from three cancer types in SEER.

as cancer survival prediction, correlation of medical factors,
management of diseases recurrence, and etc.
Again, the main purpose of this study is to investigate the
possibility of being diagnosed with cancers given a previous
medical condition. To model such a disease development, in
this study we focus on three types of cancer data from SEER,
including lung and bronchus cancer (C1), liver and intrahepatic
bile duct cancer (C2), and stomach cancer (C3), respectively.
Figure 1 shows the percentage of selected patient samples from
three types of cancers.

2.4. Summary
In this section, we briefly review some existing research on
applying the data-mining techniques in the medical domain.
Additionally, we also offer a fundamental discussion on three
popular methods, including the Artificial Neural Network, Naïve
Bayes, and Markov chain model. Based on these three methods,
we will then propose a novel prediction algorithm to monitor and
predict patients’ disease development, which is discussed in the
coming sections.

4. PROPOSED APPROACH
In this section, we propose a novel prediction algorithm by
combining three different methods, including the Bayesian and
Markov models, as well as the artificial neural network. Our
approach is based on the assumption that the occurrence of a
new type of cancer incidence is affiliated with the most recently
(or previously) diagnosed cancer incidence, as well as patients’
previous clinical details. Toward this end, Naïve Bayesian and
Markov chain models are first used to establish the connection
between the previous and current incidence, which offers a useful
estimation of patient’s future status. Then, the output from the
two probabilistic models will be cast as the network input for
the training process. Additionally, to improve the accuracy and
learning efficiency, we further leverage a sparse training strategy
for the target network. The pipeline of the proposed algorithm is
then illustrated in Figure 2. Next, we will discuss different stages
within our proposed algorithm.

3. STUDY BACKGROUND
The National Cancer Institute (NCI) established the Surveillance,
Epidemiology and End Results (SEER) database in 19731 .
This incidence database consists of de-identified patient data
with different types of cancer diseases. Additionally, for each
patient record, there are in total 124 features. These features
cover both the demographical and clinical information. For
example, demographics information include gender, ethnicity,
year of birth, month, and year of diagnosis, age, and marital
status of patients at diagnosis. Clinical information includes
tumor primary site, tumor marker, tumor size, the types of
treatment received, behavior codes, laterality, and histology.
In addition, the cancer types involved in the database can be
divided into nine categories: breast, colon and rectum, other
digestive systems, female reproduction, lymphoid and leukemia,
male reproduction, respiratory system, urinary system and other
unspecified types. By November 2013, there were more than
1 million data records in the SEER database. Currently, it is
the authoritative data source that provides reliable data support
for clinical research. A huge number of research efforts have
been conducted to utilize this database for different work, such
1 Available online

4.1. Data Pre-processing
To begin with, the first stage is to preprocess the original SEER
data to meet certain criteria, such as removal of missing values
and data normalization. Among all 124 features, 19 independent
features that may have an impact on the cancer prediction tasks
were selected, including: gender, race, status, age, primary site,
etc. The detail description and value distribution of selected
attributes are provided in Table 2.

at: https://seer.cancer.gov.
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FIGURE 2 | The workflow of the proposed algorithm for predicting patients’ disease development.

Next, we find that selected attributes can be divided into
discrete and continuous attributes. For discrete attributes, it is
easy to process compared to continuous ones. For example, the
marital status attribute is divided into seven categories, while the
gender one is cast into two categories. By contrast, for continuous
data, the minimum-maximum normalization is employed in a
way that the values from continuous features will be limited
p
within the range of [0, 1]. Mathematically, let vj be the value
from the p-th sample and the j-th continuous feature, min(vj )
and max(vj ) is the minimal and maximal value of this j-th feature
p
from all samples. Accordingly, the normalized value v̂j will be

Among these features, four of them, namely SS_SURG,
CSLYMPHN, EOD10_SZ, and CSEXTEN, contain massive
amounts of missing values, ∼50% on average. One plausible
reason could be the patients’ refusal to provide adequate
information. On the other hand, due to the evolution of
SEER over time, some clinical features have only been
collected in recent years. This makes it very impractical
to backtrack those new features from previous records. For
simplicity, patients’ records with missing values will be removed
in this study. That is, only completed data samples will
be considered.
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variable on a patient’s medical condition at the time they are
p
p
diagnosed with Di . Let {vij } be the attribute list of the p-th
patient. Accordingly, in the Bayes theory, we will have:

TABLE 2 | Variable descriptions and unique values.
Variable name Description

Unique value count

PUBCSNUM

Patient’s number

1,885,421

SEQ_NUM

Sequence number of all reported incidence 15

YEAR_DX

Year of diagnosis

Continuous

MDXRECMP

Month of diagnosis

12

SEX

Patient’s gender

2

MAR_STAT

Marital status at diagnosis

7

RACE1V

Patient ethnicity

30

AGE_DX

Patient’s age at diagnosis

Continuous

PRIMSITE

Primary site

51

LATERAL

Laterality

6

FIRSTPRM

First malignant primary indicator

2

HISTREC

Histology

37

GRADE

Histologic grading and differentiation

5

NO_SURG

Reason no cancer-directed surgery

8

EOD10_SZ

Tumor size

Continuous

SS_SURG

Site-specific surgery

30

CSLYMPHN

Involvement of lymph nodes

63

CSEXTEN

Extension of tumor

Continuous

ERSTATUS

Tumor marker 1–breast cancer

5

PRSTATUS

Tumor marker 2–breast cancer

5

p

vj − min(vj )
max(vj ) − min(vj )

p

p

p

p

p

(5)

where K is the number of attributes. Alternatively, we have
p

p

p

p

p

P(Di+1 |vi1 , vi2 , ...viK ) ∝ P(Di+1 )

K
Y

p

p

P(vij |Di+1 ).

(6)

j=1
p

p

The conditional probability P(vij |Di+1 ) can be calculated using
the Laplace smoothing while avoiding the zero probability:
p

p
p
P(vij |Di+1 )

=

p

N(Di+1 , vij ) + 1
p

N(Di+1 ) + K

.

(7)

On the other hand, we assume that the next disease relies
primarily on the precedent disease, as well as the patient’s
current status. As such, the Markov chain model is accordingly
employed to capture the probabilistic information conveyed by
the sequence of diseases, that is identified from patients’ medical
history. In this study, we consider the first-order Markov model,
and accordingly we can estimate the probability of the next
disease as follows:

p

p

p

P(vi1 |Di+1 )P(vi2 |Di+1 )...P(viK |Di+1 )P(Di+1 ),

estimated as follows:
v̂j =

p

p

p

p

P(Di+1 |vi1 , vi2 , ...viK ) ∝

.

(4)

p

p

p

p

p

p

p

P(Di+1 |Di , Di−1 , ..., D2 , D1 ) = P(Di+1 |Di ).

4.2. Estimation of Subsequent
Disease-Development

p

(8)

p

Furthermore, the probability of P(Di+1 |Di ) is calculated
as follows:

In this section, we will discuss the second stage of calculating
the possibility of the subsequent disease-development, using the
concept of Naïve Bayes and Markov chain model. Suppose we
p
p
p
p
have a set of cancer diagnoses {Di , {vij }Kj=1 }τi=1 , where Di is the i-

p

p

th new type of cancer disease of patient p, and vij is the jth feature
of the i-th new cancer diagnosis of patient p, K is the number of
p
attributes of the set {vij }, and τ p is the total number of cancer
types occurring for patient p. Then the research question can
be reformulated as follows: given a patient’s most-recent cancer
p
diagnosis Di and the set of patient health profile information
p
at the time of diagnosis {vij }Kj=1 , the task is to predict the next

p

N(Di+1 , Di )
p

N(Di )

,

(9)

p

where N(Di+1 , Di ) is the number of patients with a disease Di+1
p
occurring right after the disease of Di , and similarly N(Di ) is the
p
total number of patients with the disease Di .
To incorporate both most-recent diagnosis and the patient’s
health condition into our proposed model, the above Markov
and Naïve Bayes models are combined. Operating under the
p
p
assumption that the patient’s health condition set vi and Di are
p
independently conditioned on Di+1 , the combination of the two
models can be performed using the following approximation:

p

most likely type of cancer to occur for that patient Di+1 . For
example, patient P had been diagnosed with liver cancer before.
In this case, we will investigate the following likelihood of patient
P having other types of cancers (such as lung or stomach cancer).
As a result, mathematically, our goal is to estimate the probability
that patient P with the i-th disease Di will also develop the
p
p
(i + 1)-th disease Di+1 , or the probability P(Di+1 |Di , vi ).
To address the aforementioned problem, we introduce a novel
estimation method to calculate the posterior probability based
on Naïve Bayes and Markov chain models. More precisely, with
Naïve Bayes, we can investigate the dependence of the target
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p

p

P(Di+1 |Di ) =

p

p

p

p

P(Di+1 |Di , vi ) =
=
p

p

p

p

p

p

p

P(Di+1 |Di ) P(Di+1 |vi1 ,vi2 ,...,viK )
p

p

C(Di ,vi )
p
p
P(Di+1 |Di )

p

,

P(Di+1 )
QK
p
p
p p
j=1 P(vij |Di+1 ),
C(Di ,vi )
p

(10)

p

where P(Di+1 |Di ) and P(vij |Di+1 ) can be estimated by the
p

p

Markov and Naïve Bayes models, respectively, and C(Di , vi ) is
the normalization factor to ensure all probabilities summed to 1.
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4.3. ANN Training

The proposed sparse training is then used to optimize the
network structure, by selecting the most-important hidden
neurons, while minimizing the output error simultaneously.
Therefore, the neuron selection process is equivalent to finding
a sparse representation for all hidden neurons. Consequently,
the sparse training process is then cast as solving the
following problem:

The previous section describes the details about the estimation
of subsequent disease development. In the third stage of our
proposed algorithm, the output from the previous stage will be
cast as the input to feed into a neural network. Figure 3 illustrates
the structured input for ANN, while the probability estimation,
together with the patient’s profile, such as gender and age, are
considered as a whole to train the network.
As for the network training process, internal weights will be
optimized in a way that the actual network output fits the desired
outputs well. Taken as an example, the backpropagation (BP)based method is a typical way to train ANN via calculating
gradients of the output error in relation to network weights.
However, the BP-based training could suffer from some
drawbacks, such as low convergence and poor generalization
capability, in particular with a huge number of input features.
In the context of our study, the network has 20 input features,
which could be time-consuming for implementing the BPbased training.
To improve the training stability and the fast training speed,
we adopt a sparse training strategy in this study, similar to
our preliminary work in Yang and Ma (2016, 2019). The
general idea is to generate a sparse network structure and to
minimize the training error simultaneously. The concept of
sparse representation, on the other hand, is under the assumption
that a signal can be decomposed into a linear combination of
few elementary signals. Consequently, given the target matrix
Y ∈ RM×L and a known dictionary matrix D ∈ RM×N that
contains N columns, the sparse representation aims to minimize
the solution sparsity and the reconstruction error:
X ∗ = arg min M (X) subject to kY − DXk2 6 ǫ,

min kW2 k2,1

≤ ǫ,

(14)

In previous sections, we discuss three different stages from the
proposed algorithm. Overall, we apply the Naïve Bayes and
Markov chain model to estimate the probability of potential
disease development. We then consider this probability result
as the additional input, together with other original features, for
training a network. At last, to minimize the impact from the huge
number of input features, a sparse training strategy is further
leveraged to optimize the network structure and minimize the
training error simultaneously. Toward this end, Algorithm 1
summarizes the proposed method for investigating the cancerrisk analysis.

(11)

Algorithm 1 : Proposed algorithm for cancer-risk prediction,
based on an improved probabilistic neural network.
Stage 1: Data preprocessing, in terms of feature selection,
removal of missing records, and perform data normalization.
Stage 2: Calculate the probability based on Equation (10).
Stage 3: Employ the probability result and original input
features for network training:
Stage 3.1: Randomly assign weights to the input-hidden layer;
Stage 3.2: Solve the optimization problem in Equation (14) to
obtain a spare weight matrix for the hidden-output layer;
Output the trained neural network.

(12)

5. EXPERIMENTAL RESULTS
This section describes experimental results by applying the
proposed algorithm to explore a patient’s disease development.
The experimental setup and evaluation metrics are presented
in section 5.1. In section 5.2, we discuss the probabilities based
on their historical information and individual profiles, while

(13)

where f2 (·) is the activation function for the output layers.
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4.4. Summary

where f1 (·) is the activation function of the hidden layer, and the
i-th column from Z is in relation to the output of the i-th hidden
neuron. Furthermore, the actual output from the entire network
Ŷ can be written as:
Ŷ = f2 (ZW2 ) ,

Ỹ − ZW2

where kW2 k2,1 is the l2,1 -norm of the W2 matrix, Ỹ =
f2−1 (Y), and ǫ is the bound on the network error. Note that
in the proposed sparse training, we only consider optimizing or
sparsifying the weight matrix W2 between the hidden and output
layer. As for the weight matrix W1 in the previous input-andhidden layer, we only randomly initialize once during the training
and fix them in the subsequent process. The reason is 2-fold: (1)
the training performance heavily depends on the output layer, so
we focus on the W2 optimization, instead of both layers; (2) W2
is trained or adjusted based on the given W1 , as such a random
W1 matrix has a minimal impact on the final output.

where M (X) is a measure of the matrix sparsity, kY − DXk2
denotes the reconstruction error, and ǫ is the bound on the error.
One simple strategy for estimating M
P (X) is to consider the l2,1 norm of X, or M (X) = kXk2,1 = q kXq k2 , where Xq denotes
the q-th row of X.
Suppose there are L pairs (xi , yi ) of inputs xi and desired
outputs yi , while X = [x1 , x2 , ..., xL ] represents the entire input
matrix and Y = y1 , y2 , ..., yL is the desired output matrix.
Additionally, assume that the target network is with a threelayer structure, which consists of Q-input, N-hidden and Moutput neurons, respectively. Let W1 ∈ RQ×N and W2 ∈ RN×M
denote the weight matrices from the hidden and output layer,
respectively. As such, the output matrix from the hidden layer
(Z) can be expressed as:
Z = f1 (XW1 ) ,

subject to
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FIGURE 3 | Input structured data for ANN training.

value. Lastly, the following metrics are employed to evaluate
the performance:

the performance of the proposed method is then evaluated in
section 5.3.

5.1. Experimental Setup

Recall =

The target dataset includes 10,500 patients with lung cancer,
13,500 with liver cancer, and 12,000 with stomach cancer,
respectively, which is a total of 36,000 samples. Each original
sample has 19 features, while the majority of chosen features
are categorical (or discrete), except for four attributes, such as
the patient’s age at diagnosis, year of diagnosis, tumor size,
and extension of tumor. Again, continuous features will be
normalized as described in section 4.1 during the pre-processing
stage. We further applied the 3-fold cross validation method
to randomly partition the entire dataset into two independent
sets: a training and testing set. The size of the training and
testing sets in all cases is 75 and 25%, respectively. The training
set is used for training the network while the testing set is for
evaluation purposes.
Additionally, for the employed neural network, we consider
the activation function of the hidden and output layer as the
1
Sigmoid function, which can be expressed as f (z) = [1+exp(−z)]
(z is an arbitrary input). The layer between the input-andhidden is initialized with random weights in the range [-1,
+1]. The number of hidden neurons is set as 64. To solve the
optimization problem in Equation (14), the orthogonal matching
pursuit (OMP) algorithm is employed2 , which first measures the
similarity between the residual error and the neuron outputs, and
then selects the neuron that minimizes the residual error at each
iteration. To halt the OMP solver, the termination criterion is
set either when the maximal iteration (K) is reached or when
kǫ −ǫ k22
is less than a threshold α, where ǫk is
the value of kkǫ k−1
k2

Precision =

F1 Score = 2 ×

Precision × Recall
,
Precision + Recall

(16)

(17)

5.2. Probabilities for Disease Prediction
In this section, we discuss the result of patients’ disease
probabilities using their previous medical information. As
mentioned before, this temporary result, obtained from Naïve
Bayes and Markov chain model, will be cast as the input to the
subsequent network training. Therefore, an accurate estimation
of posterior probabilities will certainly enhance the network
performance. Before we discuss the result, the detail of forming
the patients’ historical information is provided first. Again, we
are interested in three types of cancers in this study: lung, liver,
and stomach cancer. As such, the entire dataset is grouped by
the patient ID. These records are further sorted based on the
date of disease diagnosis, while records are indexed from 0, and
the maximum number of incidences from a patient is five. Note
that some patients could have the problem of recurrence, thereby
leading to more than three records. Next, the following procedure
is considered:

k 2

1. If the patient only has one type of cancer, then her/his record
is added directly to the final dataset;

at: https://scikit-learn.org.
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TP
,
TP + FP

(15)

where TP denotes the true positive rate, FN is false negative rate,
and FP represents the false positive, respectively.

the output error at the k-th iteration, and α is a user-defined
2 Available online

TP
,
TP + FN
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TABLE 4 | Comparison of evaluation metrics from the training dataset.

TABLE 3 | Patient’s conditional probabilities.

p

p
N(Di+1
, Dip )

N(Dip )

p
P(Di+1
|Dip , vijp )

p

10,864

24,085

0.4346

p

13,726

26,421

0.5756

p

6,821

16,548

p

10,889

p

p

Di+1 = C1, Di = C2
p
Di+1
p
Di+1
p
Di+1
p
Di+1
p
Di+1

= C3, Di = C2
= C2, Di = C1
= C3, Di = C1
= C2, Di = C3
= C1, Di = C3

ANN (%)

CBM (%)

Proposed (%)

Overall accuracy

73.55

76.07

75.63

RECALL (C1)

98.64

98.84

98.05

0.3753

RECALL (C2)

86.29

87.48

87.42

17,009

0.6588

RECALL (C3)

46.14

49.61

50.92

2,112

6,981

0.3631

Precision (C1)

69.28

72.49

71.73

3,219

6,811

0.6312

Precision (C2)

59.72

63.02

63.07

Precision (C3)

89.42

91.76

90.84

F1 score (C1)

80.46

83.74

82.57

F1 score (C2)

73.81

76.49

75.38

F1 score (C3)

58.21

61.18

60.72

Note that we label lung and bronchus cancer as C1, liver and intrahepatic bile duct cancer
as C2, and stomach cancer as C3, respectively.

2. If the patient has a recurrence, then records with same type are
merged by maintaining only one sample with the latest date
of diagnosis.

Again, the labels of C1, C2, and C3 represent the lung and bronchus, liver and intrahepatic
bile duct cancer, and stomach cancer, respectively.

Through the aforementioned process, redundant patients’
records are removed, and the sequence of disease development
is accordingly established for the following calculation. Lastly,
the estimation result of posterior probabilities, given the patients’
previous information, is presented in Table 3.
From the results presented in Table 3, there indeed exists
some connection between patients’ disease development. For
instance, we observe that the probabilities from 50% of cases
(three out of six) have exceed 57%, which indicates a potential
correlation among different diseases. The highest value is found
from patients with a type of lung cancer (C1), who have more
than a 65% possibility to develop stomach cancer (C3). On the
other hand, for patients who had stomach cancer (C3) previously,
the chance is much lower (only about 36%) to develop liver
cancer (C2). This preliminary result will then be cast as the input
for the subsequent network training, while the comparison with
other methods is discussed in the next section.

TABLE 5 | Comparison of evaluation metrics from the test dataset.
CBM (%)

Proposed (%)

Overall accuracy

68.78

70.63

72.47

RECALL (C1)

77.44

77.34

78.11

RECALL (C2)

81.82

82.03

83.79

RECALL (C3)

58.19

65.83

66.64

Precision (C1)

65.37

67.12

69.75

Precision (C2)

63.81

65.72

67.91

Precision (C3)

75.93

77.56

78.37

F1 score (C1)

78.34

75.39

78.95

F1 score (C2)

65.23

65.17

65.06

F1 score (C3)

52.89

59.52

63.63

Again, the labels of C1, C2, and C3 represent the lung and bronchus, liver and intrahepatic
bile duct cancer, and stomach cancer, respectively.

5.3. Comparison With Other Training
Algorithms

the standard ANN method. Again, the major difference among
the three methods lie in the input; the results suggest that the
additional estimation of patients’ status (based on their previous
information) is capable of providing useful information that
facilitates the subsequent ANN training.
On the other hand, we also observe the best generalization
performance of the proposed algorithm from Table 5. The results
from the test dataset indicate that the ANN performs the
worst, while the CBM method comes second. However, we also
notice that the training performance of the proposed algorithm
(75.63%) is slightly lower than that of CBM (76.07%) from
Table 4. The reason could be the overfitting of CBM to the
training data, while the employed sparse neural network helps in
improving the testing accuracy while avoiding the overfitting. As
a result, the experimental results confirm the advantage of both
the additional input from posterior probability and the sparse
training in the proposed algorithm.
Next, the performance of our algorithm is compared with
conventional methods, and the aim is to evaluate the effectiveness
of the proposed method. More precisely, the Support Vector

Note that again in our proposed algorithm, the main contribution
is 2-fold: (1) introducing the technique of Naïve Bayes and
Markov chain models to estimate the posterior possibilities; (2)
employing the sparse training strategy for the network training.
As such, the following experiments are designed to evaluate the
effectiveness of both the possibility result and the sparse training.
To begin, we consider comparing the performance of the
standard ANN, combination model with Bayes and Markov
(labeled as CBM), and the proposed models on the training and
test set, respectively. Note that in the standard ANN, original
features are directly fed into the network, while no additional
input is considered. In the CBM method, the estimation for
potential disease is considered but no additional neural network
is attached. We run the experiments 10 times, and average results
are summarized and presented in Tables 4, 5, respectively.
When it comes to the training performance, we realize that
the probability estimation for patients’ status indeed helps in
boosting the accuracy. For instance, both the CBM and proposed
algorithms achieve better training outcome compared to that of
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FIGURE 4 | Average training and testing accuracy obtained from different algorithms for prediction.

decision trees (Mayur et al., 2019). For each element tree,
RF allows them to randomly choose a subset of features
from the entire set, which enhances its flexibility and
stability. Key hyperparameters within RF include the number
of trees in the forest (n_estimators), the maximum depth
of a tree (max_depth), and the number of features for
splitting (max_features). In this study, we adopt the following:
max_depth = 5, n_estimators = 10, and max_features =
p
n_features (where n_features is the number of total features).
3. Extreme Learning Machine (ELM) is one typical network
training algorithm, which initializes the network weights
randomly and then update the weight matrix in the output
layer based on a least-square model (Wang et al., 2020).
Experiments have shown the advantage of ELM to have easy
implementation and better generalization ability, compared
to the traditional backpropagation training algorithm. As
such, ELM is introduced to make a comparison with the
proposed algorithm with a typical three-layer network, while
the number of hidden neurons is set as 64.
4. The weighted association rules algorithm (WCBA) aims to
generate association rules by combining a new attribute
evaluation and prioritization techniques (Alwidian et al.,
2018). More precisely, domain knowledge was employed to
identify attributes with high significance. Then the statistical
harmonic mean (HM) measurement was introduced to
prioritize generated rules at the pruning and generation
phases. Experimental results show its effectiveness by
comparing existing rule-based classification methods.

FIGURE 5 | Comparison of classification accuracy (ROC curves) from various
methods.

Machine and Random Forest algorithms are included in this
paper for comparison purposes:
1. Support Vector Machine (SVM) is one of the most popular
kernel-based approaches, which has been demonstrated
to perform well in various applications (Sharaf et al.,
2015). Usually, the decision boundary formed by SVM
is constructed by finding a hyperplane that achieves the
maximum separation between classes. In this study, the
implemented SVM is with the radial basis function (RBF)
kernel, while the penalty parameter C of the error term is set
as C = 0.01, and the Kernel coefficient γ is set as γ = 0.1;
2. Random Forest (RF) is one typical ensemble method, which
establishes a forest by constructing a collection of element

Frontiers in Computational Neuroscience | www.frontiersin.org

Note that for SVM, RF, ELM, and WCBA, their inputs are
from original data directly, without the additional posterior
possibility information. We ran the experiments 10 times to
obtain the average performance. As a result, both the training
and test classification accuracy from different methods are shown
in Figure 4, and the relevant ROC curves are also shown in
Figure 5. Although the SVM and RF method have performed
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better in the training cases, they seem to have problems with
overfitting. In particular, the RF method leads to the highest
accuracy of 78.93% from training, but with a poor testing
accuracy of 55.62%. A similar problem was observed in the SVM
method. By contrast, compared to those standard algorithms,
the proposed approach achieves a notable improvement in terms
of testing accuracy. For instance, our method leads to the best
testing result of 72.47%, which is significantly better than the
accuracy of SVM (69.70%), RF (55.62%), ELM (65.31%), and
WCBA (61.25%), respectively. Overall, it is empirically confirmed
that the proposed method outperforms existing training methods
by improving the generalization capability.

structure and minimize the training error simultaneously. We
test our method using one of the largest cancer-related datasets
worldwide. Experimental results suggest that our proposed
algorithm exhibits some potential for accurate predictions,
compared to other conventional methods. Future work can then
apply our method in a broader range of applications, or to
develop more sophisticated probability-based neural networks.

6. CONCLUSIONS
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